名稱 | B2M-associated HLA-G/aAPC Cell |
型號 | CBP74189 |
報(bào)價(jià) | ![]() |
特點(diǎn) | B2M-associated HLA-G/aAPC Cell |
產(chǎn)品搜索
相關(guān)文章
- ATCC細(xì)胞的細(xì)胞破碎
- VKORC1基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- ATCC細(xì)胞株的特殊性質(zhì)或標(biāo)志必須在整個(gè)培養(yǎng)期間始終存在
- CD200/CD200R篩選模型
- 【靶點(diǎn)模型+診斷質(zhì)控】EGFR vIII的藥物開發(fā)和診斷
- 潛力十足的T細(xì)胞療法,我們用得起嗎?
- 細(xì)胞株的表達(dá)量越高越好嗎?
- 細(xì)胞株的STR鑒定技術(shù)分享
- JCI:華人科學(xué)家發(fā)現(xiàn)促進(jìn)乳腺癌進(jìn)展轉(zhuǎn)移的表觀修飾閱讀者
- 【產(chǎn)品推介】VEGFR-2(KDR)小分子抑制劑細(xì)胞篩選模型
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
電話:4008750250
號碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74189B2M-associated HLA-G/aAPC Cell

- 詳細(xì)內(nèi)容
CBP74189 | |
I. Background | |
N/A | |
II. Introduction | |
Host Cell: | N/A |
Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | F12K+10%FBS+600ug/ml Hygromycin B+3ug/ml puromycin |
Mycoplasma Testing: | Negative |
Storage: | Liquid nitrogen |
Application(s): | Functional(Report Gene) Assay |
III. Representative Data | |
Figure 1. Recombinant B2M-associated HLA-G/aAPC Cell stably expressing B2M. Figure 2. Recombinant B2M-associated HLA-G/aAPC Cell stably expressing HLA-G. Figure 3. Dose Response of LILRB1 Blocking Antibody in LILRB1 Effector Reporter Cells (C13) With B2M-associated HLA-G/aAPC Cells (C15). Figure 4.Dose Response of LILRB2 Blocking Antibody in LILRB2 Effector Reporter Cells (C24) With B2M-associated HLA-G/aAPC Cells(C15). | |